Requires blood sample to be obtained from driver involved in motor vehicle accident resulting in death; designated as "Michelle Sous' Law."
Impact
The proposed law is aimed at increasing public safety by ensuring that individuals responsible for fatal accidents cannot evade accountability due to the lack of evidence of drug use. By allowing blood tests in these scenarios, the law enhances the tools of law enforcement and aims to deter impaired driving. This could potentially lead to a decrease in drug-related driving offenses in the state, thereby enhancing public road safety.
Summary
Assembly Bill A752, also known as 'Michelle Sous' Law', stipulates that a blood sample must be obtained from any driver involved in a motor vehicle accident that results in a death. This amendment expands New Jersey's existing implied consent law, which currently only applies to breath tests for determining blood alcohol content, to include blood tests for determining the presence of drugs. Under this law, blood samples can be taken upon issuance of a warrant, enabling authorities to ascertain whether drugs were involved in fatal accidents.
Contention
There are notable concerns surrounding the implications of this law, particularly regarding civil liberties and the potential for misuse of the powers granted to law enforcement. Critics may argue that mandatory blood tests could infringe on an individual's rights if the implementation lacks proper oversight. Furthermore, the discussion around this bill may raise ethical questions about consent and the potential impact on drivers involved in accidents who may not be under the influence of drugs at all.
Final_thoughts
If enacted, A752 could fundamentally alter how New Jersey addresses driving under the influence in the context of fatal accidents, marking a shift towards more stringent regulations for ensuring road safety. Stakeholders, including advocacy groups and legal experts, are likely to participate actively in discussions as the bill progresses through the legislative process.